🔗 Permalink

Inventor profile of:

David Migneault

City:

Laval

Country:

Canada

Published Applications:

Last publication date:

2024-02-29

Top Assignees for applications by David Migneault

The entities that hold a legal rights for patent applications filed by inventor Migneault David:

Neurochem (International) Limited 9 Lausanne, Switzerland
Neurochem (International) Limited 3 Walchwil, Switzerland
BHI Limited Partnership 3 Laval, Quebec, Canada
Bellus Health Inc. 3 Laval, Canada
BHI LIMITED PARTNERSHIP 2 Laval, Canada
Bellus Health (International) Limited 2 Lausanne, Switzerland
Bellus Health Inc. 1 Laval, Quebec, Canada
ISIS INNOVATION LIMITED 1 Oxford, United Kingdom
QUEEN'S UNIVERSITY AT KINGSTON 1 Kingston, Canada
Bellus Health Inc. 1 , Canada
BHI Limited Partnership 1 Quebec, Canada
The University of British Columbia 1 Vancouver, Canada

Recent patent applications by Migneault David

David Migneault from Laval, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-02-29

US20240065990A1

Human necessities

METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID

#2 | 2021-12-16

US20210386693A1

Human necessities

METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID

#3 | 2020-08-13

US20200253897A1

Human necessities

Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid

#4 | 2020-01-09

US20200009086A1

Human necessities

Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid

#5 | 2017-04-06

US20170095430A1

Human necessities

Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid

#6 | 2014-11-06

US20140329746A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES

#7 | 2014-08-07

US20140220122A1

Chemistry; metallurgy

Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid

#8 | 2014-04-17

US20140107027A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES

#9 | 2012-01-19

US20120015911A1

Chemistry; metallurgy

Method and compositions for treating amyloid-related diseases

#10 | 2011-01-27

US20110021813A1

Chemistry; metallurgy

PHARMACEUTICAL DRUG CANDIDATES AND METHODS FOR PREPARATION THEREOF

#11 | 2010-05-06

US20100113591A1

Chemistry; metallurgy

Methods and compositions for treating amyloid-related diseases

#12 | 2008-09-18

US20080227767A1

Human necessities

Methods and compounds for inhibiting amyloid deposits

#13 | 2008-07-01

US10429198

Methods and compounds for inhibiting amyloid deposits

#14 | 2008-06-19

US20080146642A1

Human necessities

Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid

#15 | 2008-01-31

US20080027097A1

Chemistry; metallurgy

PHARMACEUTICAL DRUG CANDIDATES AND METHODS FOR PREPARATION THEREOF

#16 | 2007-01-18

US20070015737A1

Human necessities

Compounds for inhibiting diseases and preparing cells for transplantation

#17 | 2007-01-11

US20070010573A1

Chemistry; metallurgy

Methods and compositions for treating amyloid-related diseases

#18 | 2006-10-05

US20060223855A1

Chemistry; metallurgy

Methods and compositions for treating amyloid-related diseases

#19 | 2006-08-17

US20060183800A1

Chemistry; metallurgy

Methods and fluorinated compositions for treating amyloid-related diseases

#20 | 2005-08-18

US20050182118A1

Human necessities

Amidine derivatives for treating amyloidosis

#21 | 2005-06-30

US20050143462A1

Human necessities

Pharmaceutical drug candidates and methods for preparation thereof

#22 | 2005-05-05

US20050096385A1

Chemistry; metallurgy

Methods and compositions for treating amyloid-related diseases

#23 | 2005-03-03

US20050048000A1

Human necessities

Amyloid targeting imaging agents and uses thereof

InventorID:

728625 ⎘